APA (7th ed.) Citation

Li, L., Freed, D. C., Liu, Y., Li, F., Barrett, D. F., Xiong, W., . . . An, Z. (2021). A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. npj vaccines, 6(1), 79-14. https://doi.org/10.1038/s41541-021-00342-3

Chicago Style (17th ed.) Citation

Li, Leike, et al. "A Conditionally Replication-defective Cytomegalovirus Vaccine Elicits Potent and Diverse Functional Monoclonal Antibodies in a Phase I Clinical Trial." Npj Vaccines 6, no. 1 (2021): 79-14. https://doi.org/10.1038/s41541-021-00342-3.

MLA (9th ed.) Citation

Li, Leike, et al. "A Conditionally Replication-defective Cytomegalovirus Vaccine Elicits Potent and Diverse Functional Monoclonal Antibodies in a Phase I Clinical Trial." Npj Vaccines, vol. 6, no. 1, 2021, pp. 79-14, https://doi.org/10.1038/s41541-021-00342-3.